Fine Lines, Wrinkles & Texture Research Update - P&G Beauty ...

eferences
21. Bissett DL, Oblong JE, Saud A, Berge CA, Trejo AV,
Biedermann KA. Topical niacinamide provides skin aging
appearance benefi ts while enhancing barrier function.
In: Baran R, Maibach HI, eds. Textbook of Cosmetic Dermatology.
Abingdon, Oxon, UK: Taylor & Francis Group.
2005: 57-62.
22. Griffi th M, Osborne R, Munger R, Xiong X, Doillon CJ,
Laycock NLC, Hakim M, Song Y, Watsky MA. Functional
human corneal equivalents constructed from cell lines.
Science 1999; 286: 2169-2172.
23. Bisset DL, Farmer T, McPhail S, Reichling T, Tiesman JP,
Juhlin KD, Hurley GJ, Robinson MK. Genomic changes
induced by topical N-acetyl glucosamine in skin equivalent
cultures in vitro. Submitted for publication; 2007.
24. Osborne R, Jarrold BB, Mullins LA. In Vitro Skin Matrix
Responses to Anti-aging Compounds. Poster presented
at the 65th American Academy of Dermatology Annual
Meeting; Washington, DC, 2007.
25. Osborne R, Mullins LA, Jarrold BB, McPhail S, Robinson L.
Evaluation of Cosmetic Ingredients in Tissue Engineered
Human Skin In Vitro. Poster presented at American Association
for Advancing Science Annual Meeting; 2007.
26. Bisset D, et al. Topical palmitoyl pentapeptide: effective
agent to reduce the appearance of facial aging. 61st
American Academy of Dermatology Annual Meeting;
San Francisco, 2003.
27. Robinson L, et al. Pentapeptide offers improvement in
human photoaged facial skin. 61st American Academy
of Dermatology Annual Meeting; San Francisco, 2003.
28. Osborne R, Robinson L. Use of a facial moisturizer
containing Pal-KTTKS peptide improves the appearance
of aging skin. 63rd American Academy of Dermatology
Annual Meeting; New Orleans, 2005.
29. Bisset DL, Miyamoto K, Sun P, Li J, Berge CA. Topical
niacinamide reduces yellowing, wrinkling, red blotchiness,
and hyperpigmented spots in aging facial skin.
Int J Cosmet Sci 2004; 26: 231-238.
30. Bisset D, Oblong J, Saud A, et al. Topical niacinamide
provides skin aging appearance benefi ts while enhancing
barrier function. J Clin Dermatol 2003; 32S: 9-18.
31. Bissett DL, Oblong JE. Cosmeceutical vitamins. In:
Draelos ZD, ed. Cosmeceuticals. Philadelphia: Elsevier
Saunders. 2005: 57.
32. Langsjoen, P. Introduction to Conenzyme q10.
http://faculty.washington.edu/ely/coenzq10.html; 1994.
33. Grosick TL, Tanner PR. Effi cacy as used, not as tested,
is true measure of sunscreen performance. 62nd
American Academy of Dermatology Annual Meeting;
Washington, DC 2004.
34. Betteridge J, et al. Visualising free radical inhibition from
topically applied antioxidants. J Am Acad Dermatol 2007;
56: AB24.
35. Kang S, et al. Applications of retinol to human skin in
vivo induces epidermal hyperplasia and cellular retinoid
binding proteins characteristic of retinoic acid but without
measurable retinoic acid levels of irritation. J Invest
Dermatol 1995; 105: 549-556.
36. Fluhr J, et al. Tolerance profi le of retinol, retinaldehyde,
and retinoic acid under maximized and long-term clinical
conditions. Deramtol 1999; 1S: 57-60.
37. Oblong JE, Abel Saud A, Bissett DL. Topical retinyl propionate
improves photoaged facial skin with a favorable
irritation profi le. Poster presented at American Academy
of Dermatology Annual Meeting; 2002.
38. Hakozaki T, Minwalla L, Zhuang J, et al. The effect of
niacinamide on reducing cutaneous pigmentation and
suppression of melanosome transfer. Br J Dermatol 2002;
147: 20-33.
39. Bissett D. Topical niacinamide and barrier enhancement.
Cutis 2002; 70S: 8-12.
Fine Lines, Wrinkles & Texture: Research Update 19